Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by SURGE Therapeutics
SURGE Therapeutics Completes Phase 1 Dosing of First-in-Category Intraoperative Immunotherapy and Prepares for Registrational Trial
February 12, 2026
From
SURGE Therapeutics
Via
Business Wire
SURGE Therapeutics Raises $32M Series B Financing to Advance Intraoperative Immunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery
July 19, 2023
From
SURGE Therapeutics
Via
Business Wire
SURGE Therapeutics Receives FDA Clearance of IND Application to Initiate Phase 1/2a Study of Intraoperative Immunotherapy in Bladder Cancer
January 04, 2023
From
SURGE Therapeutics
Via
Business Wire
SURGE Therapeutics Raises $26M Series A Financing to Accelerate Development of Intraoperative Immunotherapy to Improve Survival Outcomes Post-Surgery
October 17, 2022
From
SURGE Therapeutics
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.